Qualitest Pharmaceuticals Names Pharmaceutical Industry Veteran Robert Mills as the Company’s New President

HUNTSVILLE, Ala., May 19 /PRNewswire/ -- Qualitest Pharmaceuticals, a leading manufacturer and distributor of generic pharmaceuticals, today announced that Robert Mills has been named President. Mr. Mills, a 30-year veteran in the pharmaceutical industry, joins Qualitest from Columbia Laboratories, Inc., where he was Chief Executive Officer and President. He previously held senior management positions at Watson Pharmaceuticals, Schein Pharmaceuticals and Alpharma Inc.

Marvin Samson, Chairman and Chief Executive Officer of Qualitest Pharmaceuticals, commented, "Bob's talents and experience as a leader and in building businesses will help Qualitest grow as we strive to become one of the leading generic pharmaceutical firms in the United States. I have known Bob for many years and we have worked together in the past. We are very pleased that he has become a member of the Qualitest team."

Mr. Mills remarked, "With an excellent management team and a strong commitment to all of our stakeholders investors, employees, customers and suppliers I see in Qualitest tremendous potential for growth. I am excited about pursuing opportunities for success both today and in the future."

About Qualitest Pharmaceuticals

Founded in 1983, Qualitest provides affordable, high-quality generic pharmaceuticals. Featuring a current portfolio exceeding 600 products, the company has grown significantly since its inception. Based on the total number of prescriptions filled, Qualitest is now ranked in the top 10 among all suppliers of generic pharmaceuticals in the U.S.

Privately held by funds advised by Apax Partners Worldwide, LLP, a leading global private equity firm, Qualitest has its headquarters and distribution facilities in Huntsville, Alabama and a workforce of more than 1,100 employees in Huntsville and Charlotte, North Carolina.

SOURCE Qualitest Pharmaceuticals